THERAVECTYS TO PRESENT DETAILED PHASE I/II RESULTS FROM THE FIRST-EVER LENTIVIRAL-VECTOR

18 juillet 2015 : Theravectys to Present Detailed Phase I/II Results from the First-Ever Lentiviral-Vector Based Therapeutic Vaccine Trial at the 2015 Towards an HIV Cure Symposium. Cliquez ici pour lire le communiqué de presse